Insider Transactions in Q4 2021 at Athira Pharma, Inc. (ATHA)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 18
2021
|
Mark James Litton President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
885
+0.76%
|
$10,620
$12.51 P/Share
|
|
Nov 18
2021
|
Kevin Church CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
96
+0.22%
|
$1,152
$12.51 P/Share
|
|
Nov 18
2021
|
Hans Moebius Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
829
+2.58%
|
$9,948
$12.51 P/Share
|
|
Nov 18
2021
|
Glenna Mileson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
931
+1.02%
|
$11,172
$12.51 P/Share
|